Practical Geriatrics ›› 2023, Vol. 37 ›› Issue (11): 1170-1175.doi: 10.3969/j.issn.1003-9198.2023.11.023
Previous Articles Next Articles
Received:2022-12-20
Online:2023-11-20
Published:2023-11-22
CLC Number:
| [1] 国家老年医学中心, 中华医学会老年医学分会, 中国老年保健协会糖尿病专业委员会. 中国老年糖尿病诊疗指南(2021年版)[J]. 中华糖尿病杂志, 2021, 13(1):14-46. [2] SINCLAIR A, SAEEDI P, KAUNDAL A, et al. Diabetes and global ageing among 65-99-year-old adults: findings from the international diabetes federation diabetes atlas, 9(th) edition[J]. Diabetes Res Clin Pract, 2020, 162:108078. [3] KALYANI R R, SAUDEK C D, BRANCATI F L, et al. Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006[J]. Diabetes Care, 2010, 33(5):1055-1060. [4] FORBES A. Reducing the burden of mortality in older people with diabetes: a review of current research[J]. Front Endocrinol:Lausanne, 2020, 11:133. [5] MUNSHI M N. Cognitive dysfunction in older adults with diabetes: what a clinician needs to know[J]. Diabetes Care, 2017, 40(4):461-467. [6] MUNSHI M N, MENEILLY G S, RODRÍGUEZ-MAÑAS L, et al. Diabetes in ageing: pathways for developing the evidence base for clinical guidance[J]. Lancet Diabetes Endocrinol, 2020, 8(10):855-867. [7] BLAUM C, CIGOLLE C T, BOYD C, et al. Clinical complexity in middle-aged and older adults with diabetes: the Health and Retirement Study[J]. Med Care, 2010, 48(4):327-334. [8] KIRKMAN M S, BRISCOE V J, CLARK N, et al. Diabetes in older adults: a consensus report[J]. J Am Geriatr Soc, 2012, 60(12):2342-2356. [9] LIPSKA K J, ROSS J S, MIAO Y, et al. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control[J]. JAMA Intern Med, 2015, 175(3):356-362. [10] LIBISELLER A, LICHTENEGGER K M, DE CAMPO A, et al. Diabetes management according to health status in older adults with type 2 diabetes staying in geriatric care facilities[J]. J Diabetes Sci Technol, 2021, 15(3):615-621. [11] CHRISTIAENS A, BOLAND B, GERMANIDIS M, et al. Poor health status, inappropriate glucose-lowering therapy and high one-year mortality in geriatric patients with type 2 diabetes[J]. BMC Geriatr, 2020, 20(1):367. [12] ROONEY M R, TANG O, ECHOUFFO TCHEUGUI J B, et al. American diabetes association framework for glycemic control in older adults: implications for risk of hospitalization and mortality[J]. Diabetes Care, 2021, 44(7):1524-1531. [13] CIGOLLE C T, KABETO M U, LEE P G, et al. Clinical complexity and mortality in middle-aged and older adults with diabetes[J]. J Gerontol A Biol Sci Med Sci, 2012, 67(12):1313-1320. [14] American Diabetes Association. Standards of medical care in diabetes--2012[J]. Diabetes Care, 2012, 35 (Suppl 1):S11-S63. [15] American Diabetes Association. Older adults: standards of medical care in diabetes-2020[J]. Diabetes Care, 2020, 43(Suppl 1):S152-S162. [16] American Diabetes Association. Older adults: standards of medical care in diabetes-2021[J]. Diabetes Care, 2021, 44(Suppl 1):S168-S179. [17] DRAZNIN B, ARODA V R, BAKRIS G, et al. Older adults: standards of medical care in diabetes-2022[J]. Diabetes Care, 2022, 45(Supple1): S195-S207. [18] LEROITH D, BIESSELS G J, BRAITHWAITE S S, et al. Treatment of diabetes in older adults: an endocrine society* clinical practice guideline[J]. J Clin Endocrinol Metab, 2019, 104(5):1520-1574. [19] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1):4-67. [20] WEINER J Z, GOPALAN A, MISHRA P, et al. Use and discontinuation of insulin treatment among adults aged 75 to 79 years with type 2 diabetes[J]. JAMA Intern Med, 2019, 179(12):1633-1641. [21] CONLIN P R, COLBURN J, ARON D, et al. Synopsis of the 2017 U.S. Department of veterans affairs/U.S. department of defense clinical practice guideline: management of type 2 diabetes mellitus[J]. Ann Intern Med, 2017, 167(9):655-663. [22] American Geriatrics Society Expert Panel on the Care of Older Adults with Diabetes Mellitus. Guidelines abstracted from the American Geriatrics Society guidelines for improving the care of older adults with diabetes mellitus: 2013 update[J]. J Am Geriatr Soc, 2013, 61(11): 2020-2026. [23] Internatonal Diabetes Federation. Global guideline for managing older people with type 2 diabetes[EB/OL]. (2017-03-05) [2021-06-06]. https://www.idf.org/e-library/guidelines/78-global-guideline-for-managing-older-people-with-type-2-diabetes.html. [24] BELLARY S, KYROU I, BROWN J E, et al. Type 2 diabetes mellitus in older adults: clinical considerations and management[J]. Nat Rev Endocrinol, 2021, 17(9):534-548. [25] 吴孟娜, 冯磊, 罗旋, 等. 糖化血红蛋白与血糖的相关性[J]. 中国老年学杂志, 2022, 42(4):1019-1023. [26] 李萌, 罗樱樱, 杨晓燕, 等.年龄对糖化血红蛋白和糖化血清白蛋白筛查糖尿病的影响[J].中国糖尿病杂志, 2015, 23(5):385-389. [27] FREEMAN J. Management of hypoglycemia in older adults with type 2 diabetes[J]. Postgrad Med, 2019, 131(4):241-250. [28] AMIEL S A, ASCHNER P, CHILDS B, et al. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management[J]. Lancet Diabetes Endocrinol, 2019, 7(5): 385-396. [29] GELLER A I, SHEHAB N, LOVEGROVE M C, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations[J]. JAMA Intern Med, 2014, 174(5):678-686. [30] POLONSKY W H, PETERS A L, HESSLER D. The impact of real-time continuous glucose monitoring in patients 65 years and older[J]. J Diabetes Sci Technol, 2016, 10(4):892-897. [31] ABDELHAFIZ A H, RODRÍGUEZ-MAÑAS L, MORLEY J E, et al. Hypoglycemia in older people - a less well recognized risk factor for frailty[J]. Aging Dis, 2015, 6(2):156-167. [32] UNGER J, KUSHNER P, ANDERSON J E. Practical guidance for using the free style libre flash continuous glucose monitoring in primary care[J]. Postgrad Med, 2020, 132(4):305-313. [33] 唐伟, 张子成. 老年糖尿病血糖监测技术新进展[J]. 实用老年医学, 2022, 36(10):978-982. [34] LEE S J, LEIPZIG R M, WALTER L C. Incorporating lag time to benefit into prevention decisions for older adults[J]. JAMA, 2013, 310(24):2609-2610. [35] PILLA S J, SCHOENBORN N L, MARUTHUR N M, et al. Approaches to risk assessment among older patients with diabetes[J]. Curr Diab Rep, 2019, 19(8):59. [36] LEE A K, STEINMAN M A, LEE S J. Improving the American diabetes association framework for individualizing treatment in older adults: evaluating life expectancy[J]. BMJ Open Diabetes Res Care, 2020, 8(1):e001624. [37] ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J]. New Engl J Med, 2008, 358(24): 2560-2572. [38] WONG M G, PERKOVIC V, CHALMERS J, et al. Long-term benefits of intensive glucose control for preventing end-stage kidney disease: advance-on[J]. Diabetes Care, 2016, 39(5): 694-700. [39] 中华医学会内分泌学分会,中国成人2型糖尿病降压治疗目标研究工作组. 2型糖尿病患者认知功能障碍防治的中国专家共识[J]. 中华内分泌代谢杂志, 2022, 38(6):453-464. [40] 王双, 詹俊鲲, 程梅, 等. 中国养老机构内老年人血糖规范化管理专家共识(2021)[J]. 中华老年医学杂志, 2021, 40(6):683-694. [41] 赵元萍, 丁睿, 谢红. 中国版日常生活活动能力量表编制与信效度验证[J]. 实用老年医学, 2022, 36(12):1215-1219. [42] SINCLAIR A J, HELLER S R, PRATLEY R E, et al. Evaluating glucose-lowering treatment in older people with diabetes: lessons from the IMPERIUM trial[J]. Diabetes Obes Metab, 2020, 22(8):1231-1242. [43] GANDHI G Y, MOORADIAN A D. Management of hyperglycemia in older adults with type 2 diabetes[J]. Drugs Aging, 2022, 39(1):39-58. |
| [1] | WANG Su, ZHAO Yijing, WEI Chenmin, CHEN Kun, CAO Wen, WANG Kun, YANG Yu. Correlation of triglyceride-glucose index with low-density lipoprotein subtypes in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(10): 1002-1006. |
| [2] | GU Chonghuai, XIANG Xuejun, ZHENG Yuanxi, QIAO Rui, LIN Song. Efficacy of dapagliflozin in elderly patients undergoing coronary intervention with type 2 diabetes mellitus and ejection fraction reduced heart failure [J]. Practical Geriatrics, 2024, 38(10): 1025-1029. |
| [3] | . [J]. Practical Geriatrics, 2024, 38(10): 1066-1069. |
| [4] | LIU Qianhui, YAO Zijun, HE Yuli, XU Yunfan, WU Jun. Effects of HbA1c level on cardiac structure and function in elderly patients with type 2 diabetes mellitus and chronic heart failure [J]. Practical Geriatrics, 2024, 38(5): 491-437. |
| [5] | LIU Tongjun, ZHAO Yajie, HU Jieling, HU Yang, LIANG Wei. Effect of glucose metabolic disorders on serum levels of activin-A [J]. Practical Geriatrics, 2024, 38(5): 495-437. |
| [6] | . [J]. Practical Geriatrics, 2024, 38(5): 521-437. |
| [7] | . [J]. Practical Geriatrics, 2024, 38(5): 529-437. |
| [8] | TANG Yuan, DENG Shufang, HE Yongmei, DAI Yuxuan, LUO Jing. The status of health literacy and correlation with frailty in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(3): 255-259. |
| [9] | DAI Ling-li, YU Yun. Association of estimated glomerular filtration rate with insulin resistance and β-cell function in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2023, 37(12): 1219-1223. |
| [10] | FAN Ting-yong, YUAN Li, YANG Xiao-ling, CHEN Qian. Assessment effect of Caprini scale on venous thromboembolism in elderly patients with diabetes [J]. Practical Geriatrics, 2023, 37(12): 1233-1237. |
| [11] | ZHANG He-cheng, WEI Su. Correlation of serum ferritin level with diabetic foot in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2023, 37(11): 1111-1114. |
| [12] | HU Yan, WU Hai-di, WANG Xue-fei, LOU Qing-lin, YE Qing, GU Liu-bao, DAI Jing, SONG Xiao-bo. Correlation between diabetic foot risk score and urinary microalbumin/creatinine ratio in elderly patients with type 2 diabetes [J]. Practical Geriatrics, 2023, 37(11): 1134-1137. |
| [13] | ZHANG Lin-ying, MEI Qun-chao, ZHANG Wei-qi, HU Yi-lan. Application of resistance training combined with high milk protein nutrition in elderly patients with type 2 diabetes mellitus and sarcopenia [J]. Practical Geriatrics, 2023, 37(10): 995-999. |
| [14] | . [J]. Practical Geriatrics, 2023, 37(10): 1064-1068. |
| [15] | . [J]. Practical Geriatrics, 2023, 37(9): 882-885. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
